NCT03865134

Brief Summary

The aim of this study was to investigate the eye structure, visual impairment, visual motor development and motor coordination of children between 2-6 ages that had applied to diod laser photocoagulation and intravitreal anti - vascular endothelial growth factor treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2019

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2019

Completed
Last Updated

March 16, 2020

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

March 1, 2019

Last Update Submit

March 13, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Visual Motor Integration

    Visual-motor integration (VMI) is "the degree to which visual perception and finger-hand movements are well coordinated" and will asses with Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages. The Short Format and Full Format tests take about 10-15 minutes each to administer. Results are reported as standard scores, percentiles, and age equivalents.

    3 weeks

  • Visual Perception

    Visual perception will asses with Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages. Visual Perception test takes about 5 minutes. Results are reported as standard scores, percentiles, and age equivalents.

    3 weeks

  • Motor Coordination

    Motor Coordination is coordination of finger movements and will asses by Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages. Motor coordination test takes about 5 minutes. Results are reported as standard scores, percentiles, and age equivalents.

    3 weeks

  • Retinal Layers' Development

    Development of retinal layers will assess with Optical coherence tomography (OCT). The OCT allows for in vivo, cross-sectional assessment of eye tissue, including the retina and its vasculature. By comparing the interference patterns of light that passes through live tissue to a reference arm, OCT provides high-resolution imaging of just a few microns of eye microanatomy.

    3 weeks

Other Outcomes (2)

  • Quality of Life in Parents

    3 weeks

  • State - Trait Anxiety of Parents

    3 weeks

Study Arms (3)

Laser Group

Children with premature retinopathy treated with Laser therapy. All cases are evaluated with Snellen Test, Autorefractometer, Titmus Stereo Fly Test, Optical Kohlerans Tomography, Peabody Developmental Motor Scales - II. Investigation of Visual Motor Integration will evaluate with Beery- Buktenica Developmental Test of Visual Motor Integration and Peabody. Parents are evaluated World Health Organization Quality of Life - BREF and State - Trait Anxiety Inventory.

Diagnostic Test: Snellen TestDiagnostic Test: AutorefractometerDiagnostic Test: Titmus Stereo Fly TestDiagnostic Test: Optical Kohlerans TomographyBehavioral: Investigation of Visual Motor IntegrationBehavioral: Peabody Developmental Motor Scales - IIBehavioral: World Health Organization Quality of Life - BREFBehavioral: State - Trait Anxiety Inventory

Anti-VEGF Group

Children with premature retinopathy treated with anti-VEGF therapy. All cases are evaluated with Snellen Test, Autorefractometer, Titmus Stereo Fly Test, Optical Kohlerans Tomography, Peabody Developmental Motor Scales - II. Investigation of Visual Motor Integration will evaluate with Beery- Buktenica Developmental Test of Visual Motor Integration and Peabody. Parents are evaluated World Health Organization Quality of Life - BREF and State - Trait Anxiety Inventory.

Diagnostic Test: Snellen TestDiagnostic Test: AutorefractometerDiagnostic Test: Titmus Stereo Fly TestDiagnostic Test: Optical Kohlerans TomographyBehavioral: Investigation of Visual Motor IntegrationBehavioral: Peabody Developmental Motor Scales - IIBehavioral: World Health Organization Quality of Life - BREFBehavioral: State - Trait Anxiety Inventory

Regrese Group

Children with premature retinopathy haven't applied any invasive treatment method. All cases are evaluated with Snellen Test, Autorefractometer, Titmus Stereo Fly Test, Optical Kohlerans Tomography, Peabody Developmental Motor Scales - II. Investigation of Visual Motor Integration will evaluate with Beery- Buktenica Developmental Test of Visual Motor Integration and Peabody. Parents are evaluated World Health Organization Quality of Life - BREF and State - Trait Anxiety Inventory.

Diagnostic Test: Snellen TestDiagnostic Test: AutorefractometerDiagnostic Test: Titmus Stereo Fly TestDiagnostic Test: Optical Kohlerans TomographyBehavioral: Investigation of Visual Motor IntegrationBehavioral: Peabody Developmental Motor Scales - IIBehavioral: World Health Organization Quality of Life - BREFBehavioral: State - Trait Anxiety Inventory

Interventions

Snellen TestDIAGNOSTIC_TEST

Visual acuity measurement

Anti-VEGF GroupLaser GroupRegrese Group
AutorefractometerDIAGNOSTIC_TEST

Refraction measurement

Anti-VEGF GroupLaser GroupRegrese Group
Titmus Stereo Fly TestDIAGNOSTIC_TEST

Stereopsis measurement

Anti-VEGF GroupLaser GroupRegrese Group

Retinal development measurement

Anti-VEGF GroupLaser GroupRegrese Group

Investigation of visual motor integration, motor coordination and visual perception by Beery- Buktenica Developmental Test of Visual Motor Integration.

Anti-VEGF GroupLaser GroupRegrese Group

Evaluation of motor development

Anti-VEGF GroupLaser GroupRegrese Group

Assesment of quality of life

Anti-VEGF GroupLaser GroupRegrese Group

Assesment of anxiety

Anti-VEGF GroupLaser GroupRegrese Group

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Participants who were followed up and treated in the outpatient clinic of Zeynep Kamil Women and Children Diseases Training and Research Hospital, Ophthalmology Clinic with the diagnosis of Prematurity Retinopathy between the years 2012-2015 were included in the study.

You may qualify if:

  • Age range between 2-6 years of age
  • Gestational age range 26-34. be between weeks
  • To be diagnosed with retinopathy of prematurity
  • Neurological, hereditary and not having metabolic disease
  • Compliance with visual examinations and physiotherapy evaluations
  • To be children and parents who agree to participate in the study

You may not qualify if:

  • To be a child who does not comply with Optical Kohlerans Tomography (OCT)
  • Not participating in one or more of the eye examination or physiotherapy assessments
  • Being children and parents who do not agree to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medipol University

Istanbul, Beykoz, Turkey (Türkiye)

Location

Related Publications (3)

  • Rothman AL, Mangalesh S, Chen X, Toth CA. Optical coherence tomography of the preterm eye: from retinopathy of prematurity to brain development. Eye Brain. 2016 May 27;8:123-133. doi: 10.2147/EB.S97660. eCollection 2016.

    PMID: 28539807BACKGROUND
  • Kabatas EU, Kurtul BE, Altiaylik Ozer P, Kabatas N. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children. Curr Eye Res. 2017 Jul;42(7):1054-1058. doi: 10.1080/02713683.2016.1264607. Epub 2017 Jan 27.

    PMID: 28128986BACKGROUND
  • Araz-Ersan B, Kir N, Tuncer S, Aydinoglu-Candan O, Yildiz-Inec D, Akdogan B, Ekici B, Demirel A, Ozmen M. Preliminary anatomical and neurodevelopmental outcomes of intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. Curr Eye Res. 2015 May;40(6):585-91. doi: 10.3109/02713683.2014.941070. Epub 2014 Jul 15.

MeSH Terms

Conditions

Retinopathy of PrematurityVision DisordersPsychomotor Disorders

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurobehavioral Manifestations

Study Officials

  • Zeliha Candan Algun

    Istanbul Medipol University Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2019

First Posted

March 6, 2019

Study Start

September 20, 2018

Primary Completion

March 25, 2019

Study Completion

April 25, 2019

Last Updated

March 16, 2020

Record last verified: 2019-02

Locations